Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)
Clinical trial NCT02691182 · TERMINATED
Trial details
- NCT number
- NCT02691182
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2021-05-01
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.